CCNYSEChemicals & Allied ProductsFiscal year ends December 31
Chemours Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$12.62−0.12 (-0.94%)
Close on Oct 19, 2026
- Market cap
- $1.91B
- P/E (TTM)
- –
- Dividend yield
- 4.06%
Chemours Co revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Segment Total [Member] | $5.75B | $5.77B | $5.76B | $5.79B | $5.80B | $5.74B | $5.73B | – | – | – | – | – | 99.2% | -0.8% |
| Titanium Technologies [Member] | $2.39B | $2.39B | $2.43B | $2.50B | $2.56B | $2.58B | $2.57B | $2.59B | $2.61B | $2.64B | $2.68B | $2.64B | 41.3% | -6.4% |
| Thermal & Specialized Solutions [Member] | $2.16B | $2.17B | $2.07B | $2.01B | $1.92B | $1.84B | $1.83B | $1.85B | $1.82B | $1.82B | $1.85B | $1.79B | 37.3% | +12.7% |
| Advanced Performance Materials [Member] | $1.19B | $1.21B | $1.26B | $1.28B | $1.32B | $1.32B | $1.33B | $1.35B | $1.34B | $1.38B | $1.46B | $1.52B | 20.6% | -9.6% |
| Other Non-Reportable Segment [Member] | $48.00M | $50.00M | $50.00M | $51.00M | $53.00M | $51.00M | $54.00M | – | – | – | – | – | 0.8% | -9.4% |
| Other Segment [Member] | – | – | – | – | – | – | – | $52.00M | $56.00M | $69.00M | $85.00M | $104.00M | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Chemours's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.